Aspen Places Bid For Sigma

Reinforcing its aim to boost its presence in the fast-growing global generic medicines market, South African drugmaker Aspen Pharmacare has bid US$750mn for debt-laden Australian drugmaker Sigma Pharmaceuticals. Aspen's product portfolio contains more than 450 generic medicines, including antibiotics, antidepressants and HIV drugs, while Sigma is one of Australia's largest drug wholesalers and generic drug suppliers.

To read the full article, please choose one of the following options: